• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

症状发作后早期与晚期出现ST段抬高型心肌梗死的患者在接受直接经皮冠状动脉介入治疗后的心肌挽救情况。

Myocardial salvage after primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction presenting early versus late after symptom onset.

作者信息

Stiermaier Thomas, Eitel Ingo, de Waha Suzanne, Pöss Janine, Fuernau Georg, Thiele Holger, Desch Steffen

机构信息

University Heart Center Lübeck, Medical Clinic II (Cardiology/Angiology/Intensive Care Medicine), University Hospital Schleswig-Holstein, Ratzeburger Allee 160, 23538, Lübeck, Germany.

German Center for Cardiovascular Research (DZHK), Partner Site Hamburg/Kiel/Lübeck, Lübeck, Germany.

出版信息

Int J Cardiovasc Imaging. 2017 Oct;33(10):1571-1579. doi: 10.1007/s10554-017-1143-x. Epub 2017 Apr 24.

DOI:10.1007/s10554-017-1143-x
PMID:28439734
Abstract

Primary percutaneous coronary intervention (PCI) is the treatment of choice in patients with ST-elevation myocardial infarction (STEMI) presenting within 12 h of symptom onset. A benefit in the subacute stage is less clear. The aim of the present analysis was to compare myocardial salvage and infarct size between patients with early and late reperfusion after STEMI. We compared cardiac magnetic resonance (CMR) data from a randomized controlled trial (RCT) in STEMI patients presenting within 12 h (n = 695) and a RCT of subacute STEMI patients presenting between 12 and 48 h (n = 93) after symptom onset. CMR imaging was performed 3.9 ± 6.3 days after myocardial infarction. Analyses were performed for an unmatched cohort comprising all patients (n = 788) and a cohort matched for area at risk (n = 186). In the overall cohort, area at risk was similar in both groups [37.1 ± 16.1% of left ventricular mass (%LV) vs. 38.3 ± 16.2%LV; p = 0.50]. Compared to STEMI patients with early reperfusion, patients with late PCI demonstrated larger infarct size (18.0 ± 12.5%LV vs. 28.9 ± 16.9%LV; p < 0.01) and higher extent of microvascular obstruction (1.5 ± 2.9%LV vs. 2.7 ± 4.1%LV; p = 0.01). Myocardial salvage index was significantly smaller in patients with late reperfusion (52.1 ± 25.9 vs. 27.4 ± 26.0; p < 0.01). Analysis of the matched cohorts confirmed the decreased myocardial salvage (p < 0.01) and increased infarct size (p < 0.01) in case of late reperfusion. Compared to patients with timely primary PCI, late reperfusion after STEMI results in decreased myocardial salvage and increased infarct size. However, salvageable myocardium was also found in subacute stages of STEMI.

摘要

直接经皮冠状动脉介入治疗(PCI)是症状发作12小时内就诊的ST段抬高型心肌梗死(STEMI)患者的首选治疗方法。在亚急性期的获益尚不清楚。本分析的目的是比较STEMI患者早期和晚期再灌注后的心肌挽救情况和梗死面积。我们比较了一项针对症状发作12小时内就诊的STEMI患者的随机对照试验(RCT)(n = 695)和一项针对症状发作12至48小时后就诊的亚急性STEMI患者的RCT(n = 93)的心脏磁共振(CMR)数据。心肌梗死后3.9±6.3天进行CMR成像。对包括所有患者的非匹配队列(n = 788)和根据危险区域匹配的队列(n = 186)进行分析。在整个队列中,两组的危险区域相似[左心室质量的37.1±16.1%(%LV)对38.3±16.2%LV;p = 0.50]。与早期再灌注的STEMI患者相比,晚期PCI患者的梗死面积更大(18.0±12.5%LV对28.9±16.9%LV;p < 0.01),微血管阻塞程度更高(1.5±2.9%LV对2.7±4.1%LV;p = 0.01)。晚期再灌注患者的心肌挽救指数明显较小(52.1±25.9对27.4±26.0;p < 0.01)。对匹配队列的分析证实,晚期再灌注时心肌挽救减少(p < 0.01),梗死面积增加(p < 0.01)。与及时进行直接PCI的患者相比,STEMI后晚期再灌注导致心肌挽救减少和梗死面积增加。然而,在STEMI的亚急性期也发现了可挽救的心肌。

相似文献

1
Myocardial salvage after primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction presenting early versus late after symptom onset.症状发作后早期与晚期出现ST段抬高型心肌梗死的患者在接受直接经皮冠状动脉介入治疗后的心肌挽救情况。
Int J Cardiovasc Imaging. 2017 Oct;33(10):1571-1579. doi: 10.1007/s10554-017-1143-x. Epub 2017 Apr 24.
2
Benefit From Reperfusion With Primary Percutaneous Coronary Intervention Beyond 12 Hours of Symptom Duration in Patients With ST-Segment-Elevation Myocardial Infarction.ST 段抬高型心肌梗死患者症状发作 12 小时后行直接经皮冠状动脉介入治疗再灌注可获益。
Circ Cardiovasc Interv. 2018 Sep;11(9):e006842. doi: 10.1161/CIRCINTERVENTIONS.118.006842.
3
Thrombus Aspiration in Patients With ST-Segment Elevation Myocardial Infarction Presenting Late After Symptom Onset.症状发作后晚期出现 ST 段抬高型心肌梗死患者的血栓抽吸。
JACC Cardiovasc Interv. 2016 Jan 25;9(2):113-22. doi: 10.1016/j.jcin.2015.09.010.
4
Efficacy and Safety of a Pharmaco-Invasive Strategy With Half-Dose Alteplase Versus Primary Angioplasty in ST-Segment-Elevation Myocardial Infarction: EARLY-MYO Trial (Early Routine Catheterization After Alteplase Fibrinolysis Versus Primary PCI in Acute ST-Segment-Elevation Myocardial Infarction).半剂量阿替普酶与直接经皮冠状动脉介入治疗在 ST 段抬高型心肌梗死中的疗效和安全性:EARLY-MYO 试验(阿替普酶溶栓后早期常规冠状动脉造影与急性 ST 段抬高型心肌梗死直接经皮冠状动脉介入治疗的比较)。
Circulation. 2017 Oct 17;136(16):1462-1473. doi: 10.1161/CIRCULATIONAHA.117.030582. Epub 2017 Aug 27.
5
Impact of Initial Culprit Vessel Flow on Infarct Size, Microvascular Obstruction, and Myocardial Salvage in Acute Reperfused ST-Elevation Myocardial Infarction.急性再灌注ST段抬高型心肌梗死中初始罪犯血管血流对梗死面积、微血管阻塞及心肌挽救的影响
Am J Cardiol. 2016 Nov 1;118(9):1316-1322. doi: 10.1016/j.amjcard.2016.07.056. Epub 2016 Aug 13.
6
NHLBI-Sponsored Randomized Trial of Postconditioning During Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction.NHLBI 赞助的 ST 段抬高型心肌梗死患者直接经皮冠状动脉介入治疗中后处理的随机试验。
Circ Res. 2019 Mar;124(5):769-778. doi: 10.1161/CIRCRESAHA.118.314060.
7
Association Between Early Q Waves and Reperfusion Success in Patients With ST-Segment-Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention: A Cardiac Magnetic Resonance Imaging Study.早期Q波与接受直接经皮冠状动脉介入治疗的ST段抬高型心肌梗死患者再灌注成功之间的关联:一项心脏磁共振成像研究
Circ Cardiovasc Interv. 2017 Mar;10(3). doi: 10.1161/CIRCINTERVENTIONS.116.004467.
8
Association of smoking with myocardial injury and clinical outcome in patients undergoing mechanical reperfusion for ST-elevation myocardial infarction.ST段抬高型心肌梗死接受机械再灌注治疗患者吸烟与心肌损伤及临床结局的相关性
Eur Heart J Cardiovasc Imaging. 2017 Jan;18(1):39-45. doi: 10.1093/ehjci/jew030. Epub 2016 Mar 13.
9
Antecedent hypertension and myocardial injury in patients with reperfused ST-elevation myocardial infarction.再灌注ST段抬高型心肌梗死患者的既往高血压和心肌损伤
J Cardiovasc Magn Reson. 2016 Nov 11;18(1):80. doi: 10.1186/s12968-016-0299-1.
10
Randomized comparison of pre-hospital-initiated facilitated percutaneous coronary intervention versus primary percutaneous coronary intervention in acute myocardial infarction very early after symptom onset: the LIPSIA-STEMI trial (Leipzig immediate prehospital facilitated angioplasty in ST-segment myocardial infarction).症状发作后极早期行院前启动的辅助经皮冠状动脉介入治疗与直接经皮冠状动脉介入治疗治疗急性心肌梗死的随机比较:LIPSIA-STEMI 试验(莱比锡即刻院前辅助 ST 段抬高型心肌梗死血管成形术)
JACC Cardiovasc Interv. 2011 Jun;4(6):605-14. doi: 10.1016/j.jcin.2011.01.013.

引用本文的文献

1
Impact of coronary revascularization on clinical outcomes of postacute myocardial infarction patients with left ventricular thrombus.冠状动脉血运重建对急性心肌梗死后左心室血栓患者临床结局的影响。
Res Pract Thromb Haemost. 2025 May 21;9(4):102897. doi: 10.1016/j.rpth.2025.102897. eCollection 2025 May.
2
Characteristics, management and outcome of patients with late-arrival STEMI in the Acute Coronary Syndrome Israeli Surveys (ACSIS).急性冠状动脉综合征以色列调查(ACSIS)中晚期就诊ST段抬高型心肌梗死患者的特征、管理及结局
Int J Cardiol Heart Vasc. 2024 Jul 27;53:101476. doi: 10.1016/j.ijcha.2024.101476. eCollection 2024 Aug.
3

本文引用的文献

1
Thrombus Aspiration in Patients With ST-Segment Elevation Myocardial Infarction Presenting Late After Symptom Onset.症状发作后晚期出现 ST 段抬高型心肌梗死患者的血栓抽吸。
JACC Cardiovasc Interv. 2016 Jan 25;9(2):113-22. doi: 10.1016/j.jcin.2015.09.010.
2
Relationship of T2-Weighted MRI Myocardial Hyperintensity and the Ischemic Area-At-Risk.T2加权磁共振成像心肌高信号与缺血危险区的关系
Circ Res. 2015 Jul 17;117(3):254-65. doi: 10.1161/CIRCRESAHA.117.305771. Epub 2015 May 13.
3
2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI).
Macrophage-driven cardiac inflammation and healing: insights from homeostasis and myocardial infarction.
巨噬细胞驱动的心脏炎症与修复:从稳态和心肌梗死中获得的认识。
Cell Mol Biol Lett. 2023 Oct 19;28(1):81. doi: 10.1186/s11658-023-00491-4.
4
Assessing the condition of percutaneous coronary intervention services in Africa: challenges and prospects for advancement - a review.评估非洲经皮冠状动脉介入治疗服务的状况:进展面临的挑战与前景——综述
Ann Med Surg (Lond). 2023 May 24;85(6):2814-2820. doi: 10.1097/MS9.0000000000000924. eCollection 2023 Jun.
5
Late Presenters with ST-Elevation Myocardial Infarction: A Call to Action.ST段抬高型心肌梗死的延迟就诊者:行动呼吁
J Clin Med. 2022 Sep 1;11(17):5169. doi: 10.3390/jcm11175169.
6
Late primary angioplasty (beyond 12 h): are we sure it should be avoided?晚期直接血管成形术(超过12小时):我们确定应该避免吗?
Eur Heart J Suppl. 2021 Oct 8;23(Suppl E):E36-E39. doi: 10.1093/eurheartj/suab086. eCollection 2021 Oct.
7
Interstitial changes after reperfused myocardial infarction in swine: morphometric and genetic analysis.再灌注心肌梗死后猪的间质变化:形态计量学和遗传学分析。
BMC Vet Res. 2020 Jul 29;16(1):262. doi: 10.1186/s12917-020-02465-6.
8
Clinical outcome following late reperfusion with percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.ST段抬高型心肌梗死患者经皮冠状动脉介入治疗晚期再灌注后的临床结局
Eur Heart J Acute Cardiovasc Care. 2021 Jun 30;10(5):523–531. doi: 10.1177/2048872619886312. Epub 2020 May 18.
9
Time-Dependent Myocardial Necrosis in Patients With ST-Segment-Elevation Myocardial Infarction Without Angiographic Collateral Flow Visualized by Cardiac Magnetic Resonance Imaging: Results From the Multicenter STEMI-SCAR Project.心脏磁共振成像显示 ST 段抬高型心肌梗死患者无侧支循环血流与时间依赖性心肌坏死:来自多中心 STEMI-SCAR 项目的结果。
J Am Heart Assoc. 2019 Jun 18;8(12):e012429. doi: 10.1161/JAHA.119.012429. Epub 2019 Jun 11.
10
Thrombus aspiration in patients with ST-elevation myocardial infarction presenting late after symptom onset: long-term clinical outcome of a randomized trial.症状发作后晚期出现 ST 段抬高型心肌梗死的患者行血栓抽吸:一项随机试验的长期临床结局。
Clin Res Cardiol. 2019 Nov;108(11):1208-1214. doi: 10.1007/s00392-019-01452-8. Epub 2019 Mar 11.
2014年欧洲心脏病学会/欧洲心胸外科学会心肌血运重建指南:欧洲心脏病学会(ESC)和欧洲心胸外科学会(EACTS)心肌血运重建特别工作组编写,欧洲经皮心血管介入协会(EAPCI)提供特别贡献。
Eur Heart J. 2014 Oct 1;35(37):2541-619. doi: 10.1093/eurheartj/ehu278. Epub 2014 Aug 29.
4
Intracoronary versus intravenous abciximab bolus in patients with ST-segment elevation myocardial infarction: 1-year results of the randomized AIDA STEMI trial.ST段抬高型心肌梗死患者冠状动脉内注射与静脉注射阿昔单抗推注的比较:随机AIDA STEMI试验的1年结果
J Am Coll Cardiol. 2013 Sep 24;62(13):1214-5. doi: 10.1016/j.jacc.2013.06.014. Epub 2013 Jul 10.
5
The assessment of area at risk and myocardial salvage after coronary revascularization in acute myocardial infarction: comparison between CMR and SPECT.急性心肌梗死后冠状动脉血运重建后危险区和心肌挽救的评估:CMR 与 SPECT 的比较。
JACC Cardiovasc Imaging. 2013 Mar;6(3):358-69. doi: 10.1016/j.jcmg.2012.10.018.
6
Intracoronary compared with intravenous bolus abciximab application during primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: cardiac magnetic resonance substudy of the AIDA STEMI trial.急性 ST 段抬高型心肌梗死患者行直接经皮冠状动脉介入治疗时冠状动脉内与静脉内推注阿昔单抗的比较:AIDA STEMI 试验的心脏磁共振子研究。
J Am Coll Cardiol. 2013 Apr 2;61(13):1447-54. doi: 10.1016/j.jacc.2013.01.048. Epub 2013 Feb 27.
7
2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.2013年美国心脏病学会基金会/美国心脏协会ST段抬高型心肌梗死管理指南:美国心脏病学会基金会/美国心脏协会实践指南工作组报告
J Am Coll Cardiol. 2013 Jan 29;61(4):e78-e140. doi: 10.1016/j.jacc.2012.11.019. Epub 2012 Dec 17.
8
Intracoronary versus intravenous bolus abciximab during primary percutaneous coronary intervention in patients with acute ST-elevation myocardial infarction: a randomised trial.急性 ST 段抬高型心肌梗死患者行直接经皮冠状动脉介入治疗时冠状动脉内与静脉内推注阿昔单抗的随机试验。
Lancet. 2012 Mar 10;379(9819):923-931. doi: 10.1016/S0140-6736(11)61872-2. Epub 2012 Feb 21.
9
Intracoronary compared with intravenous bolus abciximab application during primary percutaneous coronary intervention: design and rationale of the Abciximab Intracoronary versus intravenously Drug Application in ST-Elevation Myocardial Infarction (AIDA STEMI) trial.经皮冠状动脉介入治疗时冠状动脉内与静脉内推注阿昔单抗的比较:急性 ST 段抬高型心肌梗死中阿昔单抗冠状动脉内与静脉内药物应用(AIDA STEMI)试验的设计和原理。
Am Heart J. 2010 Apr;159(4):547-54. doi: 10.1016/j.ahj.2009.12.038.
10
Impact of primary coronary angioplasty delay on myocardial salvage, infarct size, and microvascular damage in patients with ST-segment elevation myocardial infarction: insight from cardiovascular magnetic resonance.ST 段抬高型心肌梗死患者经皮冠状动脉介入治疗延迟对心肌挽救、梗死面积和微血管损伤的影响:心血管磁共振的观察。
J Am Coll Cardiol. 2009 Dec 1;54(23):2145-53. doi: 10.1016/j.jacc.2009.08.024.